Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-24-026878

CEO sold 9,790 shares at $23.35 ($228,597)

  • CEO acquired 91,725 shares (other)
  • CEO acquired 17,662 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Shah Gaurav · CEO

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2024-05-14 Exercise or conversion : show line 1 in the form +7,979 636,451 D
2024-05-14 Exercise or conversion : show line 2 in the form +9,683 646,134 D
2022-02-14 Other acquisition : show line 3 in the form +23,940 670,074 D
2023-02-14 Other acquisition : show line 4 in the form +67,785 737,859 D
2024-05-16 Sale : show line 5 in the form −9,790 $23.35 $228,597 728,069 D
Open-market sales · 9,790 sh · avg $23.35 · $228,597

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2024-05-14 Exercise or conversion : show line 6 in the form Restricted Stock Units −7,979 23,940 D
2024-05-14 Exercise or conversion : show line 7 in the form Restricted Stock Units −9,683 67,785 D
2022-02-14 Other disposition : show line 8 in the form Restricted Stock Units −23,940 0 D
2023-02-14 Other disposition : show line 9 in the form Restricted Stock Units −67,785 0 D
Loading xslF345X05/form4.xml…